Omada Health, Inc.
OMDA
$12.61
$0.040.32%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 260.21M | 232.34M | 209.83M | 189.67M | 169.80M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 260.21M | 232.34M | 209.83M | 189.67M | 169.80M |
| Cost of Revenue | 89.27M | 82.93M | 76.93M | 72.24M | 66.92M |
| Gross Profit | 170.94M | 149.41M | 132.90M | 117.43M | 102.88M |
| SG&A Expenses | 142.23M | 133.44M | 124.40M | 115.65M | 110.61M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 272.18M | 254.70M | 238.19M | 223.73M | 213.45M |
| Operating Income | -11.97M | -22.35M | -28.36M | -34.06M | -43.65M |
| Income Before Tax | -12.78M | -26.19M | -32.24M | -37.62M | -47.14M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -12.78 | -26.19 | -32.24 | -37.62 | -47.14 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -12.78M | -26.19M | -32.24M | -37.62M | -47.14M |
| EBIT | -11.97M | -22.35M | -28.36M | -34.06M | -43.65M |
| EBITDA | -6.48M | -17.03M | -23.17M | -29.05M | -38.85M |
| EPS Basic | -1.35 | -2.48 | -3.61 | -4.77 | -6.15 |
| Normalized Basic EPS | -0.82 | -1.53 | -2.26 | -2.98 | -3.84 |
| EPS Diluted | -1.36 | -2.48 | -3.61 | -4.77 | -6.15 |
| Normalized Diluted EPS | -0.83 | -1.53 | -2.26 | -2.98 | -3.84 |
| Average Basic Shares Outstanding | 145.93M | 95.82M | 45.95M | 31.63M | 30.88M |
| Average Diluted Shares Outstanding | 151.80M | 95.82M | 45.95M | 31.63M | 30.88M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |